Abstract:Type 1A diabetes (T1D) is believed to be caused by immune-mediated destruction of β-cells, but the immunological basis for T1D remains controversial. Microbial diversity promotes the maturation and activation of certain immune subsets, including CD161bright CD8+ mucosal associated invariant T (MAIT) cells, and alterations in gut mucosal responses have been reported in type 1 diabetics (T1Ds). We analyzed T cell populations in peripheral blood leukocytes from juvenile T1Ds and healthy controls. We found that pr… Show more
“…MR1‐5‐OP‐RU tetramers now permit the identification of MAIT cells based on their MR1‐restricted TCR specificity. Because many clinical studies have used surrogate phenotyping techniques, and often only focus on CD8 + MAIT cells in their analysis, we felt it was important to determine how well these approaches compare to the use of MR1 tetramers to examine all MAIT cell populations. Here, we analyzed a large cohort of healthy human PBMC samples to both establish the phenotypic characteristics of human MAIT cells, and subsets thereof, using MR1‐5‐OP‐RU tetramers, as well as to establish a comparison of the use of MR1‐5‐OP‐RU tetramers with surrogate mAb‐based identification techniques.…”
Section: Discussionmentioning
confidence: 99%
“…MAIT cells also appear to be perturbed in several noninfectious diseases, including autoimmunity, metabolic disorders and cancer, as well as viral infection . With growing interest in the field of MAIT cell biology, correct identification of MAIT cells is critical to determine their role in health and disease.…”
Mucosal-associated invariant T (MAIT) cells represent up to 10% of circulating human T cells. They are usually defined using combinations of non-lineage-specific (surrogate) markers such as anti-TRAV1-2, CD161, IL-18Rα and CD26. The development of MR1-Ag tetramers now permits the specific identification of MAIT cells based on T-cell receptor specificity. Here, we compare these approaches for identifying MAIT cells and show that surrogate markers are not always accurate in identifying these cells, particularly the CD4 fraction. Moreover, while all MAIT cell subsets produced comparable levels of IFNγ, TNF and IL-17A, the CD4 population produced more IL-2 than the other subsets. In a human ontogeny study, we show that the frequencies of most MR1 tetramer MAIT cells, with the exception of CD4 MAIT cells, increased from birth to about 25 years of age and declined thereafter. We also demonstrate a positive association between the frequency of MAIT cells and other unconventional T cells including Natural Killer T (NKT) cells and Vδ2 γδ T cells. Accordingly, this study demonstrates that MAIT cells are phenotypically and functionally diverse, that surrogate markers may not reliably identify all of these cells, and that their numbers are regulated in an age-dependent manner and correlate with NKT and Vδ2 γδ T cells.
“…MR1‐5‐OP‐RU tetramers now permit the identification of MAIT cells based on their MR1‐restricted TCR specificity. Because many clinical studies have used surrogate phenotyping techniques, and often only focus on CD8 + MAIT cells in their analysis, we felt it was important to determine how well these approaches compare to the use of MR1 tetramers to examine all MAIT cell populations. Here, we analyzed a large cohort of healthy human PBMC samples to both establish the phenotypic characteristics of human MAIT cells, and subsets thereof, using MR1‐5‐OP‐RU tetramers, as well as to establish a comparison of the use of MR1‐5‐OP‐RU tetramers with surrogate mAb‐based identification techniques.…”
Section: Discussionmentioning
confidence: 99%
“…MAIT cells also appear to be perturbed in several noninfectious diseases, including autoimmunity, metabolic disorders and cancer, as well as viral infection . With growing interest in the field of MAIT cell biology, correct identification of MAIT cells is critical to determine their role in health and disease.…”
Mucosal-associated invariant T (MAIT) cells represent up to 10% of circulating human T cells. They are usually defined using combinations of non-lineage-specific (surrogate) markers such as anti-TRAV1-2, CD161, IL-18Rα and CD26. The development of MR1-Ag tetramers now permits the specific identification of MAIT cells based on T-cell receptor specificity. Here, we compare these approaches for identifying MAIT cells and show that surrogate markers are not always accurate in identifying these cells, particularly the CD4 fraction. Moreover, while all MAIT cell subsets produced comparable levels of IFNγ, TNF and IL-17A, the CD4 population produced more IL-2 than the other subsets. In a human ontogeny study, we show that the frequencies of most MR1 tetramer MAIT cells, with the exception of CD4 MAIT cells, increased from birth to about 25 years of age and declined thereafter. We also demonstrate a positive association between the frequency of MAIT cells and other unconventional T cells including Natural Killer T (NKT) cells and Vδ2 γδ T cells. Accordingly, this study demonstrates that MAIT cells are phenotypically and functionally diverse, that surrogate markers may not reliably identify all of these cells, and that their numbers are regulated in an age-dependent manner and correlate with NKT and Vδ2 γδ T cells.
“…In humans, MAIT cells are identified using anti-Vα7.2 TCR chain and anti-CD161 antibodies. A recent report analyzed that the CD161 bright CD8 + T cell subset in juvenile T1D patients ( 51 ), with the CD161 bright CD8 + T cells displaying a phenotype, IL-18Rα + , CD127 + , CD45RA − , and CCR7 − , suggestive of MAIT cells. No difference in the CD161 bright CD8 + T cell frequency was observed in juvenile T1D patients as compared to age-matched controls.…”
Type 1 diabetes (T1D) and type 2 diabetes (T2D) are multifactorial diseases with different etiologies in which chronic inflammation takes place. Defects in invariant natural killer T (iNKT) cell populations have been reported in both T1D and T2D patients, mouse models and our recent study revealed mucosal-associated invariant T (MAIT) cell defects in T2D and obese patients. Regarding iNKT cells many studies in non-obese diabetic mice demonstrated their protective role against T1D whereas their potential role in human T1D is still under debate. Studies in mouse models and patients suggest that iNKT cells present in adipose tissue (AT) could exert a regulatory role against obesity and associated metabolic disorders, such as T2D. Scarce data are yet available on MAIT cells; however, we recently described MAIT cell abnormalities in the blood and ATs from obese and T2D patients. These data show that a link between MAIT cells and metabolic disorders pave the way for further investigations on MAIT cells in T1D and T2D in humans and mouse models. Furthermore, we hypothesize that the gut microbiota alterations associated with T1D and T2D could modulate iNKT and MAIT cell frequency and functions. The potential role of iNKT and MAIT cells in the regulation of metabolic pathways and their cross-talk with microbiota represent exciting new lines of research.
“…17 The notion that MAIT cell numbers and phenotype are influenced to a large extent by impairment of glucose metabolism is further supported by the correlation between MAIT cell numbers and their phenotype to the hemoglobin A1c levels in children with T1D. 18 Thus, it is possible that the increased MAIT cell activation and reduced circulating numbers observed in children with T1D may be directly linked to hyperglycemia rather than being part of the b-cell destructive process.…”
Mucosal-associated invariant T (MAIT) cells are innate T cells that recognize bacteria-infected cells and are thought to play a role in autoimmune diseases. Translocation of duodenal bacteria and viruses to the pancreas through the pancreatic duct has been hypothesized to initiate an innate inflammatory response that could contribute to the development of type 1 diabetes, a process that could involve MAIT cells. In this study, we used immunohistochemistry and quantitative PCR to search for evidence of MAIT cells in the insulitic lesions in the pancreas of human patients recently diagnosed with type 1 diabetes. Only a few scattered MAIT cells were found within the exocrine parenchyma in all pancreatic samples, but no MAIT cells were found in association to the islets. Also, only low gene expression levels of the MAIT T-cell receptor Vα7.2-Jα33 were found in the pancreas of patients with type 1 diabetes, in similar levels as that in nondiabetic organ donors used as control. The absence of MAIT cells shown in insulitic lesions in humans questions the direct cytotoxic role of these cells in β-cell destruction.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.